HIGHLIGHTS
- who: from the Pembrolizumab as a promising intervention for advanced penile cancer _______________________________________________ Daniela Vinueza-Obando, Philippe ESpiess, Herney Andru00e9s Garcu00eda-Perdomo, UROGIV Research Group. School of Medicine. Universidad del Valle. Cali, Colombia have published the Article: EXPERT OPINION, in the Journal: (JOURNAL)
- what: Considering that there are no clinical trials to guide systemic therapy recommendations, the authors aimed to discuss the effectiveness and safety of pembrolizumab in patients with locally advanced or metastatic penile SCC.
- future: There are other molecular alterations found using Foundation One that might be essential for future analysis . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.